The best stories of the day, in your inbox

AstraZeneca Vaccine Linked to Rare Blood Clot Disorder, Study Finds


Over a week after AstraZeneca announced a global withdrawal of its Covid-19 vaccine, new research has linked it to a rare and potentially fatal blood clotting disorder. The vaccine, sold in India under the brand name Covishield, has been associated with Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT).

Here are the key findings from AstraZeneca Vaccine:

  1. VITT Emergence: VITT emerged in 2021 during the Covid-19 pandemic, particularly after the use of the Oxford-AstraZeneca vaccine, which is based on adenovirus vectors.
  2. Autoantibody Targeting: Scientists discovered that VITT is caused by a harmful blood autoantibody targeting a protein called platelet factor 4 (PF4). An autoantibody is produced by the immune system and mistakenly attacks the body’s own tissues, leading to autoimmune diseases.
  3. Similarity to Natural Adenovirus Infections: Separate research in 2023 revealed a similar, sometimes fatal disorder linked to natural adenovirus infections (such as the common cold), involving the same PF4 antibody.
  4. Clinical Presentation: Affected patients often develop blood clots in unusual places like the brain or abdomen. They also have elevated levels of a substance called D-dimer in their blood.
  5. Genetic Risk Factor: Flinders University researchers identified a genetic risk factor related to the PF4 antibody in 2022.
  6. Common Factor in Viruses and Vaccines: The recent study shows that a common factor in viruses and vaccines triggers these harmful antibodies.

While the overall risk of VITT remains low, health authorities continue to monitor vaccine safety. As always, individuals should consult with healthcare professionals and make informed decisions regarding vaccination1

If you have concerns about this particular vaccine, it’s crucial to discuss them with your doctor, who can advise you based on your individual health profile. Remember, staying informed is crucial for public health, and ongoing research helps us better understand vaccine-related risks and benefits. 🌐

The Thirty Meter Telescope (TMT) is a groundbreaking project that promises to

The highly anticipated sequel to the 1996 vigilante action film

Google Pixels haven’t always been perfect, occasionally suffering from fundamental

Indian ride-hailing giant Ola has switched gears in its navigation

Assam’s flood situation continues to be critical, with over 24.5

The Zika virus has been in the news in recent

Motorola has officially unveiled the Razr 50 Ultra in India, and it’s

Bajaj Auto, the renowned Indian two-wheeler manufacturer, unveiled the world’s

Pakistan’s Punjab province is proposing a six-day ban on social

London, July 5, 2024: Keir Starmer, the leader of the UK’s

Apple announced a suite of features designed specifically for Indian

Hurricane Beryl tore through the southeastern Caribbean islands earlier this

A 14-year-old boy in Kerala succumbed to amoebic meningoencephalitis, a

In yet another incident raising concerns about infrastructure safety, a

Veteran BJP leader and former Deputy Prime Minister Lal Krishna

In a significant diplomatic engagement on the sidelines of the

In a tragic incident that has raised questions about civic

In an embarrassing security lapse for the US Navy, a

Kenya erupted in violence on Tuesday as protests against a

The Karnataka government has taken a firm stance on food

The iconic Ram Janmabhoomi temple in Ayodhya faced an unexpected

In a nail-biting encounter plagued by rain interruptions, Afghanistan scripted

Meta is bringing its artificial intelligence (AI) assistant, Meta AI,

Securities and Exchange Board of India (Sebi), the capital market

As heavy monsoon rains continue to lash parts of Sikkim,

Get daily updates in your inbox. Subscribe to our newsletter.